Please assess the completion status of the following clinical trial:

Trial Title: A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* For women of childbearing potential: agreement to remain abstinent (refrain from heterosexual intercourse) or use contraceptive methods that result in a failure rate of less than (\<) 1 percent (%) per year for at least 30 days after the last fluorescein dye administration~* The study is being conducted in participants with GA in both Study Eye and Non-Study Eye (bilateral GA) with no evidence of prior or active choroidal neovascularization (CNV)~Exclusion Criteria:~* Previous participation in any studies of investigational drugs for GA or dry AMD (except for studies of vitamins and minerals)~* GA in either eye due to causes other than AMD~* History of vitrectomy surgery, submacular surgery, or any surgical intervention for AMD~* Previous laser photocoagulation for CNV, diabetic macular edema, retinal vein occlusion, and/or proliferative diabetic retinopathy~* Any ocular or systemic medical conditions that, in the opinion of the investigator, could contribute to participant's inability to participate in the study or interfere with study assessments~* Requirement for continuous use of therapy indicated in Prohibited Therapy in the study Protocol

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cohort Geographic Atrophy (Type: None): Cohort of participants with GA secondary to AMD will be evaluated for changes in GA over time.

Based on this trial design, predict the completion outcome and termination type (if applicable).